Article Details
Retrieved on: 2018-02-08 19:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>The top biopharma story of the week involves the fast-moving field of lung cancer, which, as we've written previously, has several key trials reading out in 2018. A big domino fell this week: data from a two-drug immunotherapy combination developed by Bristol-Myers Squibb. But the results, touted as ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here